Organization

Everfront Biotech

3 clinical trials

Clinical trial

A Phase I/IIa Study to Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety and Efficacy Profile of EF-009 in Patients With Pancreatic Cancer

Status: Not yet recruiting, Estimated PCD: 2025-12-01

Clinical trial

Everfront Biotech Co., Ltd.

Status: Active (not recruiting), Estimated PCD: 2023-04-30

Clinical trial

A Phase I Study to Determine the Maximum Tolerated Dose (MTD) of HK-001 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers

Status: Active (not recruiting), Estimated PCD: 2024-12-31